Marnix J M van Agtmaal1, Alfons J H M Houben1, Frans Pouwer2, Coen D A Stehouwer1, Miranda T Schram3. 1. Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands2Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands. 2. Department of Psychology, University of Southern Denmark, Odense, Denmark. 3. Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands2Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands4Heart and Vascular Center, Maastricht University Medical Center, Maastricht, the Netherlands.
Abstract
Importance: The etiologic factors of late-life depression are still poorly understood. Recent evidence suggests that microvascular dysfunction is associated with depression, which may have implications for prevention and treatment. However, this association has not been systematically reviewed. Objective: To examine the associations of peripheral and cerebral microvascular dysfunction with late-life depression. Data Sources: A systematic literature search was conducted in MEDLINE and EMBASE for and longitudinal studies published since inception to October 16, 2016, that assessed the associations between microvascular dysfunction and depression. Study Selection: Three independent researchers performed the study selection based on consensus. Inclusion criteria were a study population 40 years of age or older, a validated method of detecting depression, and validated measures of microvascular function. Data Extraction and Synthesis: This systematic review and meta-analysis has been registered at PROSPERO (CRD42016049158) and is reported in accordance with the PRISMA and MOOSE guidelines. Data extraction was performed by an independent researcher. Main Outcomes and Measures: The following 5 estimates of microvascular dysfunction were considered in participants with or without depression: plasma markers of endothelial function, albuminuria, measurements of skin and muscle microcirculation, retinal arteriolar and venular diameter, and markers for cerebral small vessel disease. Data are reported as pooled odds ratios (ORs) by use of the generic inverse variance method with the use of random-effects models. Results: A total of 712 studies were identified; 48 were included in the meta-analysis, of which 8 described longitudinal data. Data from 43 600 participants, 9203 individuals with depression, and 72 441 person-years (mean follow-up, 3.7 years) were available. Higher levels of plasma endothelial biomarkers (soluble intercellular adhesion molecule-1: OR, 1.58; 95% CI, 1.28-1.96), white matter hyperintensities (OR, 1.29; 95% CI, 1.19-1.39), cerebral microbleeds (OR, 1.18; 95% CI, 1.03-1.34), and cerebral (micro)infarctions (OR, 1.30; 95% CI, 1.21-1.39) were associated with depression. Among the studies available, no significant associations of albuminuria and retinal vessel diameters with depression were reported. Longitudinal data showed a significant association of white matter hyperintensities with incident depression (OR, 1.19; 95% CI, 1.09-1.30). Conclusions and Relevance: This meta-analysis shows that both the peripheral and cerebral forms of microvascular dysfunction are associated with higher odds of (incident) late-life depression. This finding may have clinical implications because microvascular dysfunction might provide a potential target for the prevention and treatment of depression.
Importance: The etiologic factors of late-life depression are still poorly understood. Recent evidence suggests that microvascular dysfunction is associated with depression, which may have implications for prevention and treatment. However, this association has not been systematically reviewed. Objective: To examine the associations of peripheral and cerebral microvascular dysfunction with late-life depression. Data Sources: A systematic literature search was conducted in MEDLINE and EMBASE for and longitudinal studies published since inception to October 16, 2016, that assessed the associations between microvascular dysfunction and depression. Study Selection: Three independent researchers performed the study selection based on consensus. Inclusion criteria were a study population 40 years of age or older, a validated method of detecting depression, and validated measures of microvascular function. Data Extraction and Synthesis: This systematic review and meta-analysis has been registered at PROSPERO (CRD42016049158) and is reported in accordance with the PRISMA and MOOSE guidelines. Data extraction was performed by an independent researcher. Main Outcomes and Measures: The following 5 estimates of microvascular dysfunction were considered in participants with or without depression: plasma markers of endothelial function, albuminuria, measurements of skin and muscle microcirculation, retinal arteriolar and venular diameter, and markers for cerebral small vessel disease. Data are reported as pooled odds ratios (ORs) by use of the generic inverse variance method with the use of random-effects models. Results: A total of 712 studies were identified; 48 were included in the meta-analysis, of which 8 described longitudinal data. Data from 43 600 participants, 9203 individuals with depression, and 72 441 person-years (mean follow-up, 3.7 years) were available. Higher levels of plasma endothelial biomarkers (soluble intercellular adhesion molecule-1: OR, 1.58; 95% CI, 1.28-1.96), white matter hyperintensities (OR, 1.29; 95% CI, 1.19-1.39), cerebral microbleeds (OR, 1.18; 95% CI, 1.03-1.34), and cerebral (micro)infarctions (OR, 1.30; 95% CI, 1.21-1.39) were associated with depression. Among the studies available, no significant associations of albuminuria and retinal vessel diameters with depression were reported. Longitudinal data showed a significant association of white matter hyperintensities with incident depression (OR, 1.19; 95% CI, 1.09-1.30). Conclusions and Relevance: This meta-analysis shows that both the peripheral and cerebral forms of microvascular dysfunction are associated with higher odds of (incident) late-life depression. This finding may have clinical implications because microvascular dysfunction might provide a potential target for the prevention and treatment of depression.
Authors: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: Noa Vardi; Nanette Freedman; Hava Lester; John M Gomori; Roland Chisin; Bernard Lerer; Omer Bonne Journal: Psychiatry Res Date: 2011-04-11 Impact factor: 3.222
Authors: Sean M Lanting; Nathan A Johnson; Michael K Baker; Ian D Caterson; Vivienne H Chuter Journal: J Sci Med Sport Date: 2016-06-01 Impact factor: 4.319
Authors: J R C Almeida; T C T F Alves; M Wajngarten; J Rays; C C Castro; Q Cordeiro; R M S Telles; R J Fraguas; G F Busatto Journal: Braz J Med Biol Res Date: 2005-03-08 Impact factor: 2.590
Authors: E H B M Gronenschild; D M J Muris; M T Schram; U Karaca; C D A Stehouwer; A J H M Houben Journal: Microvasc Res Date: 2013-08-26 Impact factor: 3.514
Authors: Grazyna Rajkowska; Gouri Mahajan; Beata Legutko; Lavanya Challagundla; Michael Griswold; Paul R Albert; Mireille Daigle; Jose J Miguel-Hidalgo; Mark C Austin; Randy D Blakely; David C Steffens; Craig A Stockmeier Journal: Neuroscience Date: 2017-07-13 Impact factor: 3.590
Authors: Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Lana L Watkins; Benson M Hoffman; Andrew Sherwood Journal: Am J Geriatr Psychiatry Date: 2018-06-28 Impact factor: 4.105
Authors: Anna E. Leeuwis; Nick A. Weaver; J. Matthijs Biesbroek; Lieza G. Exalto; Hugo J. Kuijf; Astrid M. Hooghiemstra; Niels D. Prins; Philip Scheltens; Frederik Barkhof; Wiesje M. van der Flier; Geert Jan Biessels Journal: J Psychiatry Neurosci Date: 2019-07-01 Impact factor: 6.186
Authors: Laura Perna; H W Wahl; J Weberpals; L Jansen; U Mons; B Schöttker; H Brenner Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2019-03-06 Impact factor: 4.328
Authors: K A Nunley; J F Karp; T J Orchard; T Costacou; H J Aizenstein; J R Jennings; C Rosano Journal: Diabet Med Date: 2019-01-18 Impact factor: 4.359
Authors: Andrew J Petkus; Diana Younan; Xinhui Wang; Marc Serre; William Vizuete; Susan Resnick; Mark A Espeland; Margaret Gatz; Helena Chui; JoAnn E Manson; Jiu-Chiuan Chen Journal: Am J Geriatr Psychiatry Date: 2019-05-09 Impact factor: 4.105
Authors: Wenjing Wei; Helmet T Karim; Chemin Lin; Akiko Mizuno; Carmen Andreescu; Jordan F Karp; Charles F Reynolds; Howard J Aizenstein Journal: J Clin Psychiatry Date: 2018-10-23 Impact factor: 4.384
Authors: Carmen Andreescu; Olusola Ajilore; Howard J Aizenstein; Kimberly Albert; Meryl A Butters; Bennett A Landman; Helmet T Karim; Robert Krafty; Warren D Taylor Journal: Am J Geriatr Psychiatry Date: 2019-08-07 Impact factor: 4.105